Fusion IP high on drug success – ShareCast
Proactive Investors UKFusion IP high on drug successShareCastDiurnal is attempting to develop Chronocort, a modified release therapy that delivers hydrocortisone in a manner that mimics the body's normal circadian rhythm (the body's natural 24-…